Hairy oral leukoplakia: Difference between revisions

No edit summary
m (Rossdonaldson1 moved page Hairy Oral Leukoplakia to Hairy oral leukoplakia)
 
(One intermediate revision by one other user not shown)
Line 7: Line 7:
*Characterized by white plaques over the lateral sides of the tongue.
*Characterized by white plaques over the lateral sides of the tongue.
*Unlike [[oropharyngeal candidiasis]], the white plaques are unable to be scraped off.  
*Unlike [[oropharyngeal candidiasis]], the white plaques are unable to be scraped off.  
*It is asymptomatic, with most patients presenting over concern for aesthetic appearance
*Unlike other forms of leukoplakia, it is NOT a precancerous lesion
*It is asymptomatic, with most patients presenting over concern for aesthetic appearance


==Differential Diagnosis==
==Differential Diagnosis==

Latest revision as of 18:07, 6 May 2021

Background

  • It is caused by the Epstein-Barr virus (EBV)
  • Most commonly seen in immunocompromised individuals, and has a high specificity for individuals with HIV/AIDs.
  • The white plaque appearance is due to hyperkeratosis and epithelial hyperplasia.

Clinical Features

  • Characterized by white plaques over the lateral sides of the tongue.
  • Unlike oropharyngeal candidiasis, the white plaques are unable to be scraped off.
  • Unlike other forms of leukoplakia, it is NOT a precancerous lesion
  • It is asymptomatic, with most patients presenting over concern for aesthetic appearance

Differential Diagnosis

Tongue diagnoses

Oral rashes and lesions

Evaluation

  • Diagnosed clinically
  • Consider HIV testing if no other etiology is determined or if risk factors are present

Management

  • The condition is benign and does not require treatment but many patients have concerns about the aesthetic appearance.
  • Foundation of treatment is aimed at workup and management of the often underlying concomitant immunocompromised disease process.
  • High dose acyclovir can be used (4g/day), but relief is temporary and often lesions recur until immunocompromised status is reversed

Disposition

  • Discharge unless concomitant symptoms require further work-up

See Also

References

  • Chapple, IL; Hamburger, J (August 2000). "The significance of oral health in HIV disease". Sexually Transmitted Infections. 76 (4): 236–43. doi:10.1136/sti.76.4.236. PMC 1744197. PMID 11026876
  • Cherry-Peppers, G; Daniels, CO; Meeks, V; Sanders, CF; Reznik, D (February 2003). "Oral manifestations in the era of HAART". Journal of the National Medical Association. 95 (2 Suppl 2): 21S–32S. PMC 2568277. PMID 12656429.